Neonatal Hypotension: What Is the Efficacy of Each Anti-Hypotensive Intervention? A Systematic Review

Nenhuma Miniatura disponível
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Citação
CURRENT TREATMENT OPTIONS IN PEDIATRICS, v.5, n.4, p.406-416, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Purpose of review: There is no consensus in the treatment of hemodynamic instability in the preterm newborn. Blood pressure is one of the few measurable objective parameters for hemodynamic evaluation in this population. However, little is known about the efficacy of anti-hypotensive treatments in newborns. The objective of this review is to identify and analyze the efficacy of a given anti-hypotensive intervention in improving the hypotensive preterm newborn. Recent findings: With the increase in survival of the preterm newborns, there was an augmentation in the interest for the treatment of hypotension in this population. However, as there are doubts regarding the efficacy in anti-hypotensive treatment, new drugs are being used to reverse the hypotensive state in preterm infants: epinephrine, norepinephrine, vasopressin, and steroids. Summary: We have identified that classically used medications in the treatment of hypotension have little evidence of efficacy in rescuing the preterm infant from the hypotensive state. New therapies are emerging with potential benefits, especially in refractory hypotension such as epinephrine and norepinephrine, but more prospective studies are needed. Literature review should be careful, considering the definition used for hypotension, the time of onset, the intravascular volume status of each patient, and if the drug was used as a first or second line of treatment. © 2019, Springer Nature Switzerland AG.
Palavras-chave
Hypotension, Inotrope, Premature, Volume resuscitation
Referências
  1. Noori, S., Seri, I., Evidence-based versus pathophysiology-based approach to diagnosis and treatment of neonatal cardiovascular compromise (2015) Semin Fetal Neonatal Med, 20, pp. 238-245
  2. Ancel, P.Y., Goffinet, F., Kuhn, P., Langer, B., Matis, J., Hernandorena, X., Chabanier, P., Kaminski, M., Survival and morbidity of preterm children born at 22 through 34 weeks’ gestation in France in 2011 results of the EPIPAGE-2 cohort study (2015) JAMA Pediatr, 169, pp. 230-238
  3. Davis, A.L., Carcillo, J.A., Aneja, R.K., Deymann, A.J., Lin, J.C., Nguyen, T.C., Okhuysen-Cawley, R.S., Zuckerberg, A.L., The American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock (2017) Pediatric Critical Care Medicine, 18 (9), pp. 884-890
  4. Dempsey, E.M., Al Hazzani, F., Barrington, K.J., Permissive hypotension in the extremely low birthweight infant with signs of good perfusion (2009) Arch Dis Child Fetal Neonatal Ed, 94, pp. F241-F244. , COI: 1:STN:280:DC%2BD1MvivFSrtQ%3D%3D
  5. Dempsey, E., Barrington, K., Treating hypotension in the preterm infant: when and with what: a critical and systematic review (2007) J Perinatol, 27, pp. 469-478. , COI: 1:STN:280:DC%2BD2svjt1SisA%3D%3D
  6. Joynt, C., Cheung, P.-Y., Treating hypotension in preterm neonates with vasoactive medications (2018) Front Pediatr, 6, pp. 1-8
  7. Stranak, Z., Semberova, J., Barrington, K., International survey on diagnosis and management of hypotension in extremely preterm babies (2014) Eur J Pediatr, 173, pp. 793-798
  8. Development of audit measures and guidelines for good practice in the management of neonatal respiratory distress syndrome (1992) Report of a Joint Working Group of the British Association of Perinatal Medicine and the Research Unit of the Royal College of Phys. Arch Dis Child, 67, pp. 1221-1227
  9. Faust, K., Härtel, C., Preuß, M., Rabe, H., Roll, C., Emeis, M., Wieg, C., Göpel, W., Short-term outcome of very-low-birthweight infants with arterial hypotension in the first 24 h of life (2015) Arch Dis Child Fetal Neonatal Ed, 100, pp. F388-F392
  10. St Peter, D., Gandy, C., Hoffman, S.B., Hypotension and adverse outcomes in prematurity: comparing definitions (2017) Neonatology, 111, pp. 228-233. , This study suggests that hypotension, defined either by MAP less than GA by gestational age or MAP <30 mmHg, is not a risk factor related to an adverse outcome
  11. Watkins, A.M.C., West, C.R., Cooke, R.W.I., Blood pressure and cerebral haemorrhage and ischaemia in very low birthweight infants (1989) Early Hum Dev, 19, pp. 103-110. , COI: 1:STN:280:DyaL1M3ovFCmtQ%3D%3D
  12. Zubrow, A.B., Hulman, S., Kushner, H., Falkner, B., Determinants of blood pressure in infants admitted to neonatal intensive care units: a prospective multicenter study. Philadelphia Neonatal Blood Pressure Study Group (1994) J Perinatol, 15, pp. 470-479
  13. Weindling, A.M., Blood pressure monitoring in the newborn (1989) Arch Dis Child, 64, pp. 444-447. , COI: 1:STN:280:DyaL1M3nt1Wmtg%3D%3D
  14. Miall-Allen, V.M., De Vries, L.S., Whitelaw, A.G., Mean arterial blood pressure and neonatal cerebral lesions (1987) Arch Dis Child, 62, pp. 1068-1069. , COI: 1:STN:280:DyaL1c%2FkvVCnsw%3D%3D
  15. Munro, M.J., Walker, A.M., Barfield, C.P., Hypotensive extremely low birth weight infants have reduced cerebral blood flow (2004) Pediatrics, 114, pp. 1591-1596
  16. Dempsey, E.M., What should we do about low blood pressure in preterm infants (2017) Neonatology, 111, pp. 402-407
  17. Limperopoulos, C., Bassan, H., Kalish, L.A., Ringer, S.A., Eichenwald, E.C., Walter, G., Moore, M., du Plessis, A.J., Current definitions of hypotension do not predict abnormal cranial ultrasound findings in preterm infants (2007) Pediatrics, 120, pp. 966-977
  18. El-Khuffash, A., McNamara, P.J., Hemodynamic assessment and monitoring of premature infants (2017) Clin Perinatol, 44, pp. 377-393
  19. Durrmeyer, X., Marchand-Martin, L., Porcher, R., Gascoin, G., Roze, J.C., Storme, L., Favrais, G., Cambonie, G., Abstention or intervention for isolated hypotension in the first 3 days of life in extremely preterm infants: association with short-term outcomes in the EPIPAGE 2 cohort study (2017) Arch Dis Child Fetal Neonatal Ed, 102, pp. 490-497. , This study suggests that the treatment of hypotension the first 3 days of life is associated with higher survival rate without severe morbidities and a lower risk of severe brain damage, contrast to the strategy of permissive hypotension
  20. Batton, B., Zhu, X., Fanaroff, J., Kirchner, H.L., Berlin, S., Wilson-Costello, D., Walsh, M., Blood pressure, anti-hypotensive therapy, and neurodevelopment in extremely preterm infants (2009) J Pediatr, 154, pp. 351-358
  21. Batton, B., Batton, D., Riggs, T., Blood pressure during the first 7 days in premature infants born at postmenstrual age 23 to 25 weeks (2007) Am J Perinatol, 24, pp. 107-115
  22. Batton, B., Li, L., Newman, N.S., Das, A., Watterberg, K.L., Yoder, B.A., Faix, R.G., Walsh, M.C., Use of antihypotensive therapies in extremely preterm infants (2013) Pediatrics, 131, pp. e1865-e1873
  23. Gill, A.B., Weindling, A.M., Randomised controlled trial of plasma protein fraction versus dopamine in hypotensive very low birthweight infants (1993) Arch Dis Child, 69, pp. 284-287. , COI: 1:STN:280:DyaK2c%2FivFWnsw%3D%3D
  24. Rozé, J.C., Tohier, C., Lefèvre, M., Mouzard, A., Response to dobutamine and dopamine in the hypotensive very preterm infant (1993) Arch Dis Child, 69, pp. 59-63
  25. Greenough, A., Emery, E.F., Randomized trial comparing dopamine and dobutamine in preterm infants (1993) European Journal of Pediatrics, 152 (11), pp. 925-927. , COI: 1:STN:280:DyaK2c7gt1ejuw%3D%3D
  26. Klarr, J.M., Faix, R.G., Pryce, C.J., Bhatt-Mehta, V., Randomized, blind trial of dopamine versus dobutamine for treatment of hypotension in preterm infants with respiratory distress syndrome (1994) J Pediatr, 125, pp. 117-122. , COI: 1:STN:280:DyaK2c3ptlWjsA%3D%3D
  27. Hentschel, R., Hensel, D., Brune, T., Rabe, H., Jorch, G., Impact on blood pressure and intestinal pertusion of dobutamine or dopamine in hypotensive preterm infants (1995) Neonatology, 68, pp. 318-324. , COI: 1:CAS:528:DyaK28Xhtlylt7s%3D
  28. Bourchier, D., Weston, P.J., Randomised trial of dopamine compared with hydrocortisone for the treatment of hypotensive very low birthweight infants (1997) Arch Dis Child Fetal Neonatal Ed, 76, pp. 174-178
  29. Pellicer, A., Valverde, E., Elorza, M.D., Madero, R., Gaya, F., Quero, J., Cabanas, F., Cardiovascular support for low birth weight infants and cerebral hemodynamics: a randomized, blinded, clinical trial (2005) Pediatrics, 115, pp. 1501-1512
  30. Valverde, E., Dopamine versus epinephrine for cardiovascular support in low birth weight infants: analysis of systemic effects and neonatal clinical outcomes (2006) Pediatrics, 117, pp. e1213-e1222
  31. Lightburn, M.H., Gauss, C.H., Williams, D.K., Kaiser, J.R., Observational study of cerebral hemodynamics during dopamine treatment in hypotensive ELBW infants on the first day of life (2013) J Perinatol, 33, pp. 698-702. , COI: 1:CAS:528:DC%2BC3sXhsVWqs7jP
  32. Catenacci, M., Miyagi, S., Wickremasinghe, A.C., Lucas, S.S., De Alba Campomanes, A.G., Good, W.V., Clyman, R.I., Dopamine-resistant hypotension and severe retinopathy of prematurity (2013) J Pediatr, 163, pp. 400-405. , COI: 1:CAS:528:DC%2BC3sXjsFynsbo%3D
  33. Rios, D.R., Kaiser, J.R., Vasopressin versus dopamine for treatment of hypotension in extremely low birth weight infants: a randomized, blinded pilot study (2015) J Pediatr, 166, pp. 850-855. , COI: 1:CAS:528:DC%2BC2MXhvVOqsb8%3D
  34. So, K.W., Fok, T.F., Ng, P.C., Wong, W.W., Cheung, K.L., Randomised controlled trial of colloid or crystalloid in hypotensive preterm infants (1997) Arch Dis Child Fetal Neonatal Ed, 76, pp. F43-F46. , COI: 1:STN:280:DyaK2s3ht1egsg%3D%3D
  35. Heckmann, M., Trotter, A., Pohlandt, F., Lindner, W., Epinephrine treatment of hypotension in very low birthweight infants (2007) Acta Paediatr, 91, pp. 566-570
  36. Rowcliff, K., de Waal, K., Mohamed, A.L., Chaudhari, T., Noradrenaline in preterm infants with cardiovascular compromise (2016) Eur J Pediatr, 175, pp. 1967-1973. , COI: 1:CAS:528:DC%2BC28XhslSlsrnP, This retrospective study suggests that noradrenaline appears to be effective removing preterm infants from the hypotensive state, and appears to be well tolerated without major side effects
  37. Rizk, M.Y., Lapointe, A., Lefebvre, F., Barrington, K.J., Norepinephrine infusion improves haemodynamics in the preterm infants during septic shock (2018) Acta Paediatr Int J Paediatr, 107, pp. 408-413. , COI: 1:CAS:528:DC%2BC1cXisVOktrc%3D, This study shows that preterm infants with septic shock, norepinephrine was successful increasing blood pressure and improving urine output, without respiratory worsening
  38. Ikegami, H., Funato, M., Tamai, H., Wada, H., Nabetani, M., Nishihara, M., Low-dose vasopressin infusion therapy for refractory hypotension in ELBW infants (2010) Pediatr Int, 52, pp. 368-373. , COI: 1:CAS:528:DC%2BC3cXps1ags7k%3D
  39. Gaissmaier, R.E., Pohlandt, F., Ingle-Dose Dexamethasone Treatment of Hypotension
  40. Ng, P.C., A double-blind, randomized, controlled study of a “stress dose” of hydrocortisone for rescue treatment of refractory hypotension in preterm infants (2006) Pediatrics, 117, pp. 367-375
  41. Mizobuchi, M., Yoshimoto, S., Nakao, H., Time-course effect of a single dose of hydrocortisone for refractory hypotension in preterm infants (2011) Pediatr Int, 53, pp. 881-886. , COI: 1:CAS:528:DC%2BC3sXlvVegug%3D%3D
  42. Osborn, D.A., Evans, N.J., Early volume expansion for prevention of morbidity and mortality in very preterm infants (2004) Cochrane Database Syst Rev, , https://doi.org/10.1002/14651858.CD002055.pub2
  43. Saini, S.S., Kumar, P., Kumar, R.M., Hemodynamic changes in preterm neonates with septic shock (2014) Pediatr Crit Care Med, 15, pp. 443-450. , This study demonstrate that preterm newborns with septic shock have an increased cardiac output with a normal ejection fraction. This suggests that the cause of the shock is more related to a vasoplegia